By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    improving patient experience
    6 Ways to Improve Patient Satisfaction Within Hospitals
    December 1, 2021
    degree for healthcare job
    What Are The Health Benefits Of Having A Degree?
    March 9, 2022
    custom software development is changing healthcare
    Digital Customer Journey Mapping and its Importance for Healthcare
    July 21, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Can Thinking Younger Make You Live Longer?
    April 20, 2011
    Image
    Obesity’s Outlook Unchanged
    June 13, 2011
    When It’s An Emergency Elderly Not Treated As Well in Hospitals
    July 16, 2011
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Lyme Disease Vaccine: Cautionary Tale or Opportunity for Renewed Activism?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > Lyme Disease Vaccine: Cautionary Tale or Opportunity for Renewed Activism?
Public Health

Lyme Disease Vaccine: Cautionary Tale or Opportunity for Renewed Activism?

Susan Scutti
Last updated: October 4, 2013 8:00 am
Susan Scutti
Share
6 Min Read
lyme disease vaccine
SHARE

lyme disease vaccine

Contents
The Story of One VaccineActivists and Media

First published on Medical Daily

lyme disease vaccine

First published on Medical Daily

More Read

If ObamaCare Fails, Are We On to Single Payer?
Nixed NHS Procedures Spark Concern for Varicose Vein Patients
Kaiser Permanente Medical Center Allows Patients to View Charts and Info in Real Time
Obama Likely to Win the Birth Control Debate
CVS Kicks the Habit, with Implications for Consumer-Centered Healthcare

A recent New York Times opinion piece calls for a return of the vaccine for Lyme disease. “Return?” you ask. Most people never knew that a vaccine for Lyme disease ever existed. The fact is, LYMERix did exist, if only briefly, with a lifespan nearer that of a tick than of a human being: it was available from 1998 to 2002.

The history of this vaccine is somewhat complicated and, according to researchers from Children’s Hospital Boston and Harvard School of Public Health, offers us all a “cautionary tale.” In their words as published in Epidemiology and Infection, “The LYMErix case illustrates that media focus and swings of public opinion can pre-empt the scientific weighing of risks and benefits in determining success or failure.”

The Story of One Vaccine

A tick-borne illness in North America and Europe, Lyme disease is caused by a bacterium known as Borrelia burgdorferi, and it is passed by deer ticks, which feed on the blood of both animals and humans. Ticks carrying the disease thrive in grassy and heavily wooded areas, and the disease is named after the Connecticut town where a number of cases were identified during the 1970s. Early symptoms, as recorded by the Mayo Clinic, include a distinctive bulls’ eye rash and flu-like symptoms, such as chills and fever. Later symptoms include joint problems that resemble arthritis and neurological issues, including weakness and impaired movement. Typically, it is treated by a course of antibiotics, which is effective for most people, especially in the earliest stages. To prevent the disease, it is recommended that you inspect your skin for ticks and remove them promptly.

LYMERix was developed by SmithKline Beecham and approved by the U.S. Food and Drug Administration (FDA) in December 1998. The Phase III safety and efficacy trial enrolled 10,906 subjects between the ages of 15 and 70 years old, all living in endemic areas. Generally, the Northeast and Mid-Atlantic states, the Upper Midwest region, and the West Coast, specifically northern California, are the areas where the disease is considered endemic by public health officials. For SmithKline Beecham’s clinical trial, during which the vaccine was tested before being released to the general public, researchers ‘randomized’ the participants into two groups: those who received the three-dose Lyme vaccine regimen and those who received placebo injections.

“Vaccinated individuals showed a 76 percent reduction in Lyme disease in the year following vaccination, with no significant side-effects noted,” according to published research. Based on these very promising findings, the FDA approved the vaccine, though scientists noted its limitations — in particular, the fact that the safety tests did not include young children (a population at high risk for the disease). Another problem was that the FDA as well as the company producing it were uncertain as to the duration of immunity. For people who had received the vaccine, booster doses might be necessary as often as every year. Still, despite its imperfections, LYMERix was ‘suggested’ by the Advisory Committee on Immunization Practices for persons who live in an endemic area and who engage in activities that result in frequent or prolonged exposure to ticks.

All good so far, but dark clouds appeared almost immediately on the horizon.

Activists and Media

After receiving the vaccine, some people reported side effects, in particular arthritis-like complaints, previously unrecorded in the testing data. The Lyme Disease Network, a non-profit citizen action group, placed great emphasis on this, and a class action lawsuit against SmithKline Beecham was soon filed. Soon enough, the FDA reconvened its advisory panel in January 2001 to discuss the vaccine. After reviewing evidence, the FDA allowed the manufacturer to continue to sell the vaccine while requiring more data — accomplished by entering more participants in Phase IV trials of the vaccine — as to its safety and efficacy. Despite the FDA’s continued endorsement, sales dropped and in February of the following year, the company removed LYMERix from the market.

LYMERix died, then, “even though studies indicated the vaccine represented a cost-effective public health intervention for people at high risk of acquiring Lyme disease,” the researchers wrote. Clearly, Stanley A. Plotkin writing for the New York Timesagrees this amounts to a sad cautionary tale. His own son had become gravely ill due to Lyme disease but survived. Naturally, he hopes that no one else need undergo the same pain. “The experience of Glaxo has unfortunately frightened other companies away from pursuing this needed vaccine,” Plotkin stated in his published piece. “Physicians and patients should write to the C.D.C. to remind them of high public demand.” Clearly, Plotkin believes activism cuts both ways with participation entirely a matter of individual belief.

Source:  Nigrovic LE, Thompson KM. The Lyme vaccine: a cautionary tale.Epidemiology and Infection. 2006.

Original Post

TAGGED:Lyme diseasevaccine
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025
Learn how to Renew your Medical Card in West Virginia
Learn how to Renew your Medical Card in West Virginia
Health
May 15, 2025
Dr. Klaus Rentrop Shares Acute Myocardial Infarction heart treatment
Dr. Klaus Rentrop Shares Acute Myocardial Infarction
Cardiology
May 13, 2025

You Might also Like

medicaid
Health ReformNewsPolicy & LawPublic Health

Paul Krugman: Stop Being an Embarrassment to the Profession

March 7, 2013

Hospitals Build Luxury ERs to Lure Affluent Patients

November 28, 2011
primary care desert
Medical EducationPolicy & LawPublic Health

Primary Care Deserts Do Not Disappear With Nurse Practitioners

September 4, 2013

How 23andMe Got in Trouble

February 13, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?